Cerebrospinal fluid BACE1 activity and brain amyloid load in Alzheimer's disease

TheScientificWorldJournal

Volumn 2012, Issue , 2012, Pages

  Grimmer, Timo ^a   Alexopoulos, Panagiotis ^a   Tsolakidou, Amalia ^a   Guo, Liang Hao ^a   Henriksen, Gjermund ^b   Yousefi, Behrooz H ^b   Frstl, Hans ^a   Sorg, Christian ^a   Kurz, Alexander ^a   Drzezga, Alexander ^b   Perneczky, Robert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BETA SECRETASE 1; CARBON 11; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BIOLOGICAL MARKER; SECRETASE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN VENTRICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PARAHIPPOCAMPAL GYRUS; PONS; POSITRON EMISSION TOMOGRAPHY; THALAMUS; VOXEL BASED MORPHOMETRY; AGED; BRAIN; BRAIN LEVEL; CEREBROSPINAL FLUID; CHEMISTRY; ENZYMOLOGY; HIPPOCAMPUS; NEUROIMAGING; PATHOLOGY;

AGED; ALZHEIMER DISEASE; AMYLOID; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NEUROIMAGING; PONS; POSITRON-EMISSION TOMOGRAPHY; THALAMUS;

EID: 84856391201     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/712048     Document Type: Article

References (40)

1. Blennow K., Hampel H., Weiner M., Zetterberg H., Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nature Reviews Neurology 2010 6 3 131 144
2. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
3. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D. R., Price D. L., Wong P. C., BACE1 is the major -secretase for generation of A peptides by neurons Nature Neuroscience 2001 4 3 233 234 (Pubitemid 32194867)
4. Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., Teplow D. B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M. A., Biere A. L., Curran E., Burgess T., Louis J. C., Collins F., Treanor J., Rogers G., Citron M., -secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 1999 286 5440 735 741
5. Yang L. B., Lindholm K., Yan R., Citron M., Xia W., Yang X. L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y., Elevated -secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nature Medicine 2003 9 1 3 4 (Pubitemid 36098241)
6. Holsinger R. M. D., Lee J. S., Boyd A., Masters C. L., Collins S. J., CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias Neurology 2006 67 4 710 712 (Pubitemid 44273629)
7. Zhong Z., Ewers M., Teipel S., Brger K., Wallin A., Blennow K., He P., McAllister C., Hampel H., Shen Y., Levels of -secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment Archives of General Psychiatry 2007 64 6 718 726 (Pubitemid 46878672)
8. Ewers M., Zhong Z., Brger K., Wallin A., Blennow K., Teipel S. J., Shen Y., Hampel H., Increased CSF-BACE 1 activity is associated with ApoE- 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease Brain 2008 131 5 1252 1258
9. Zetterberg H., Andreasson U., Hansson O., Wu G., Sankaranarayanan S., Andersson M. E., Buchhave P., Londos E., Umek R. M., Minthon L., Simon A. J., Blennow K., Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease Archives of Neurology 2008 65 8 1102 1107
10. Fodero-Tavoletti M. T., Smith D. P., McLean C. A., Adlard P. A., Barnham K. J., Foster L. E., Leone L., Perez K., Cortés M., Culvenor J. G., Li Q. X., Laughton K. M., Rowe C. C., Masters C. L., Cappai R., Villemagne V. L., In vitro characterization of Pittsburgh compound-B binding to Lewy bodies Journal of Neuroscience 2007 27 39 10365 10371 (Pubitemid 47502018)
11. Lockhart A., Lamb J. R., Osredkar T., Sue L. I., Joyce J. N., Ye L., Libri V., Leppert D., Beach T. G., PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis Brain 2007 130 10 2607 2615 (Pubitemid 47511709)
12. Ikonomovic M. D., Klunk W. E., Abrahamson E. E., Mathis C. A., Price J. C., Tsopelas N. D., Lopresti B. J., Ziolko S., Bi W., Paljug W. R., Debnath M. L., Hope C. E., Isanski B. A., Hamilton R. L., DeKosky S. T., Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain 2008 131 6 1630 1645 (Pubitemid 351806448)
13. Ye L., Velasco A., Fraser G., Beach T. G., Sue L., Osredkar T., Libri V., Spillantini M. G., Goedert M., Lockhart A., In vitro high affinity -synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain Journal of Neurochemistry 2008 105 4 1428 1437 (Pubitemid 351590802)
14. Grimmer T., Tholen S., Yousefi B. H., Alexopoulos P., Frschler A., Frstl H., Henriksen G., Klunk W. E., Mathis C. A., Perneczky R., Sorg C., Kurz A., Drzezga A., Progression of cerebral amyloid load is associated with the apolipoprotein e 4 genotype in Alzheimer's disease Biological Psychiatry 2010 68 10 879 884
15. Kadir A., Almkvist O., Forsberg A., Wall A., Engler H., Lngstrm B., Nordberg A., Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of Aging. In press
16. Engler H., Forsberg A., Almkvist O., Blomquist G., Larsson E., Savitcheva I., Wall A., Ringheim A., Lngstrm B., Nordberg A., Two-year follow-up of amyloid deposition in patients with Alzheimer's disease Brain 2006 129 11 2856 2866 (Pubitemid 44684508)
17. Forsberg A., Engler H., Almkvist O., Blomquist G., Hagman G., Wall A., Ringheim A., Lngstrm B., Nordberg A., PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiology of Aging 2008 29 10 1456 1465
18. Fagan A. M., Mintun M. A., Mach R. H., Lee S. Y., Dence C. S., Shah A. R., LaRossa G. N., Spinner M. L., Klunk W. E., Mathis C. A., DeKosky S. T., Morris J. C., Holtzman D. M., Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Annals of Neurology 2006 59 3 512 519 (Pubitemid 43358072)
19. Forsberg A., Almkvist O., Engler H., Wall A., Lngstrm B., Nordberg A., High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters Current Alzheimer Research 2010 7 1 56 66
20. Grimmer T., Riemenschneider M., Frstl H., Henriksen G., Klunk W. E., Mathis C. A., Shiga T., Wester H. J., Kurz A., Drzezga A., Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid Biological Psychiatry 2009 65 11 927 934
21. Tolboom N., van der Flier W. M., Yaqub M., Boellaard R., Verwey N. A., Blankenstein M. A., Windhorst A. D., Scheltens P., Lammertsma A. A., van Berckel B. N. M., Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding Journal of Nuclear Medicine 2009 50 9 1464 1470
22. Degerman Gunnarsson M., Lindau M., Wall A., Blennow K., Darreh-Shori T., Basu S., Nordberg A., Larsson A., Lannfelt L., Basun H., Kilander L., Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: an exploratory study Dementia and Geriatric Cognitive Disorders 2010 29 3 204 212
23. Mosconi L., Tsui W. H., Herholz K., Pupi A., Drzezga A., Lucignani G., Reiman E. M., Holthoff V., Kalbe E., Sorbi S., Diehl-Schmid J., Perneczky R., Clerici F., Caselli R., Beuthien-Baumann B., Kurz A., Minoshima S., De Leon M. J., Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias Journal of Nuclear Medicine 2008 49 3 390 398 (Pubitemid 351355204)
24. Wenham P. R., Price W. H., Blandell G., Apolipoprotein E genotyping by one-stage PCR The Lancet 1991 337 8750 1158 1159
25. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H. C., Riemenschneider M., De Deyn P. P., Bancher C., Cras P., Wiltfang J., Mehta P. D., Iqbal K., Pottel H., Vanmechelen E., Vanderstichele H., Improved discrimination of AD patients using -amyloid(1-42) and tau levels in CSF Neurology 1999 52 8 1555 1562 (Pubitemid 29220627)
26. Drzezga A., Grimmer T., Henriksen G., Mhlau M., Perneczky R., Miederer I., Praus C., Sorg C., Wohlschlger A., Riemenschneider M., Wester H. J., Foerstl H., Schwaiger M., Kurz A., Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease Neurology 2009 72 17 1487 1494
27. Rowe C. C., Ellis K. A., Rimajova M., Bourgeat P., Pike K. E., Jones G., Fripp J., Tochon-Danguy H., Morandeau L., O'Keefe G., Price R., Raniga P., Robins P., Acosta O., Lenzo N., Szoeke C., Salvado O., Head R., Martins R., Masters C. L., Ames D., Villemagne V. L., Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Neurobiology of Aging 2010 31 8 1275 1283
28. Corder E. H., Ghebremedhin E., Taylor M. G., Thal D. R., Ohm T. G., Braak H., The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism Annals of the New York Academy of Sciences 2004 1019 24 28 (Pubitemid 38951278)
29. Vassar R., BACE1: the -secreiase enzyme in Alzheimer's disease Journal of Molecular Neuroscience 2004 23 1-2 105 113 (Pubitemid 41359193)
30. Sun A., Koelsch G., Tang J., Bing G., Localization of -secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls Experimental Neurology 2002 175 1 10 22 (Pubitemid 34507906)
31. Leuba G., Wernli G., Vernay A., Kraftsik R., Mohajeri M. H., Saini K. D., Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease Dementia and Geriatric Cognitive Disorders 2005 19 4 171 183 (Pubitemid 40522804)
32. Fukumoto H., Cheung B. S., Hyman B. T., Irizarry M. C., -secretase protein and activity are increased in the neocortex in Alzheimer disease Archives of Neurology 2002 59 9 1381 1389 (Pubitemid 35014802)
33. Schmechel A., Strauss M., Schlicksupp A., Pipkorn R., Haass C., Bayer T. A., Multhaup G., Human BACE forms dimers and colocalizes with APP Journal of Biological Chemistry 2004 279 38 39710 39717 (Pubitemid 39258240)
34. Herzig M. C., Paganetti P., Staufenbiel M., Jucker M., BACE1 and mutated presenilin-1 differently modulate A 40 and A 42 levels and cerebral amyloidosis in APPDutch transgenic mice Neurodegenerative Diseases 2007 4 2-3 127 135 (Pubitemid 47000406)
35. Irizarry M. C., Locascio J. J., Hyman B. T., -site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging The American Journal of Pathology 2001 158 1 173 177 (Pubitemid 32096482)
36. Chiocco M. J., Kulnane L. S., Younkin L., Younkin S., Evin G., Lamb B. T., Altered amyloid- metabolism and deposition in genomic-based -secretaee transgenic mice Journal of Biological Chemistry 2004 279 50 52535 52542 (Pubitemid 39662732)
37. Chiocco M. J., Lamb B. T., Spatial and temporal control of age-related APP processing in genomic-based -secretase transgenic mice Neurobiology of Aging 2007 28 1 75 84 (Pubitemid 44791642)
38. Brodbelt A., Stoodley M., CSF pathways: a review British Journal of Neurosurgery 2007 21 5 510 520 (Pubitemid 47537165)
39. Zhang E. T., Richards H. K., Kida S., Weller R. O., Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain Acta Neuropathologica 1992 83 3 233 239
40. Morris J. C., McKeel D. W., Fulling K., Torack R. M., Berg L., Validation of clinical diagnostic criteria for Alzheimer's disease Annals of Neurology 1988 24 1 17 22